Alexander Varond is a Partner in Goodwin’s Technology and Life Sciences groups and a Co-Chair of the firm’s FDA Litigation Practice. Mr. Varond advises drug, biotech, and device clients on a wide range of FDA regulatory matters. He has extensive experience in drug and medical device development, Hatch-Waxman patent and exclusivity issues, and regulatory strategy. Mr. Varond also counsels on advertising and promotional, defends companies during civil and criminal investigations, and regularly advises on corporate transactions. His perspective is bolstered by having worked closely alongside numerous in-house regulatory and legal teams through various critical projects, including NDA preparation, formal dispute resolutions, FDA and regulatory strategy advisory meetings, and product launches. Mr. Varond's professional experience includes roles as a medical device engineer, operations manager, and deputy management representative to FDA in the medical device industry. He received his J.D. from George Washington University Law School and his
B.S. from UC San Diego in Biomedical Engineering and Management Science.